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A B S T R A C T
Monepantel (MPTL) is one of two new anthelmintic compounds introduced onto the sheep market to
control gastro-intestinal nematodes. Resistance to this compound is rare but has been reported. In order
to preserve the eﬃcacy of this and other anthelmintics, it is essential to understand both (a) the mecha-
nisms involved in the selection of resistance and (b) how the parasites evolve to deal with these compounds.
To address these questions three MPTL-resistant Teladorsagia circumcincta isolates (MTci2-11, MTci5-
13 and MTci7-12) have been artiﬁcially selected in vivo from phenotypically characterised parent isolates
(MTci2, MTci5, MTci7 respectively). The selection process involved collecting and culturing eggs from sur-
viving worms from sheep administered sub-optimal dosages of MPTL (Zolvix®) to provide infective larvae
to infect further sheep until resistant isolates were generated (between 9 and 13 rounds of selection). A
controlled eﬃcacy test was conducted using the original parental isolates and the newly generated MPTL
resistant isolates (n = 5 per group). Selected isolates were assessed both under anthelmintic stress (Zolvix®,
2.5 mg/kg bodyweight; MTci-MPTL) and at rest (untreated, MTci-CON). A number of life-history traits
were assessed, namely, worm establishment rates, time to patency, faecal egg output, body length of adults
and eggs in utero. The estimated resistance status of the selected isolates was conﬁrmed with 48%, 28%
and 9% reductions in worm burden at 7-days post Zolvix® administration for MTci2-11-MPTL, MTci5-
13-MPTL andMTci7-12-MPTL, respectively, compared with untreated controls. One of the selected isolates
MTci7-12-CON showed signiﬁcantly greater total worm burden (p = 0.025), greater establishment rate
(p = 0.033), decreased time to patency (p = 0.048), higher cumulative egg outputs (p = 0.002) compared
with its parental derivative MTci7. The trial results suggest that anthelmintic selection in T. circumcincta,
albeit under experimental conditions, can select for more proliﬁc/fecund and quicker maturing popu-
lations. These data provide an insight into how parasites evolve in response to anthelmintic pressure.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Monepantel (trade name Zolvix®) was launched, ﬁrstly in New
Zealand in 2009, and then in Australia and the UK in 2010 by Novartis
Animal Health. It was the ﬁrst new drug family of anthelmintic to
appear on the livestock healthcare market for over 25 years
(Kaminsky et al., 2008). In an effort to prolong the useful life of this
new compound and protect the eﬃcacy of the older anthelmintic
families, monepantel has been sold as prescription only medicine
(POM-V) in the UK. Although efforts have been made to “protect”
the compound, the ﬁrst cases of resistance have been reported only
two years after its launch. The ﬁrst case of resistance was re-
ported in sheep and goats in New Zealand (Leathwick et al., 2013;
Scott et al., 2013) and another case was reported on a goat farm in
New SouthWales, Australia (https://wormmailinthecloud.wordpress
.com/?s=monepantel+resistance; last accessed 30APR15). All reports
have found that Teladorsagia circumcincta was one of the parasites
surviving treatment.
An understanding of the development of anthelmintic resis-
tance and evolvement of parasites in the face of anthelmintic
pressure is key to developing strategies to preserve their eﬃcacy.
Previously different selection processes for the assessment of an-
thelmintic resistance have been used: (a) comparison of anthelmintic
resistant and sensitive ﬁeld derived isolates (Le Jambre et al., 1977;
Hall et al., 1978; Kelly et al., 1978; Hunt et al., 2008, 2010); (b) ex-
perimental selection via increasing sub-therapeutic dosages in vivo
(Kates et al., 1973; Colglazier et al., 1974a; Egerton et al., 1988;
Giordano et al., 1988; Shoop et al., 1990; Rohrer et al., 1994; Ranjan
et al., 2002; Coles et al., 2005); (c) in vitro pressurisation and selection
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of individuals within a population with an inherent insensitivity to
a compound and use them for in vivo trials (Maingi et al., 1990;
Kaminsky et al., 2008); (d) comparison of populations pre- and post-
in vitro anthelmintic exposure (Laing, 2010; De Graef et al., 2013);
(e) introgression of resistant genes into sensitive populations through
the process of backcrossing individuals (Redman et al., 2012);
(f) comparison of clade V free living model nematode systems to
extrapolate information on parasitic nematodes (Driscoll et al., 1989;
Chehresa, 1996).
Phenotypic variation in life history traits following selection for
benzimidazole (BZ; Hall et al., 1978, 1981; Kelly et al., 1978; Maingi
et al., 1990; Leignel and Cabaret, 2001) and ivermectin (IV; Echevarria
et al., 1993a, 1993b) resistance has been examined previously in a
number of parasite species. Historically, it was believed that che-
motherapy that impacts on adult parasite life expectancywould result
in one of the two outcomes: either earlier development to sexual ma-
turity of parasites in order to propagate prior to treatment, or delayed
development to avoid the effects of treatment (Arneberg et al., 1998;
Skorping and Read, 1998). The ﬁnding from the aforementioned se-
lection studies would suggest that the impact of the development
of resistance on phenotypes, as one might expect, is not so clear cut,
and it is inﬂuenced by a number of host related/physiological (e.g.
age, size, diet, immune status, presence of conspeciﬁcs and hetero-
speciﬁcs) and environmental factors (Poulin, 1996).
The aims of this study were: ﬁrstly, to generate T. circumcincta
isolates selected for monepantel resistance from previously
phenotypically characterised parental isolates to improve our un-
derstandingof thedevelopment, disseminationanddetectionofMPTL
resistance and secondly, to assess the extent of phenotypic changes
that occur in selected isolates compared to parental isolates fol-
lowing selection for resistance to MPTL.
2. Materials and methods
2.1. Parasite isolates
Three T. circumcincta (designated MTci2, MTci5 and MTci7) iso-
lates were used to generate the MPTL resistant isolates, as outlined
in section 2.2 (Table 1). MTci2 is phenotypically sensitive to all broad
spectrum anthelmintics (unpublished data) whilst MTci5 andMTci7
are phenotypically BZ, levamisole (LV) and IV resistant (Sargison et al.,
2001; Bartley et al., 2004, 2005). MTci7 also exhibits moxidectin (MX)
resistance (Sargison et al., 2005; Wilson and Sargison, 2007). The
isolates were passaged through parasite naive lambs that were
housed under conditions that precluded contamination with other
nematode species prior to use. During the period of selection, the
parental isolates were independently passaged four times.
2.2. Monepantel resistance selection process
ThreeMPTL resistant T. circumcincta isolates were artiﬁcially se-
lected in vivo from phenotypically characterised isolates using an
adaptation of a previously outlinedmethodology (Coles et al., 2005).
In brief, lambs were initially mono-speciﬁcally infected with ap-
proximately 20,000 infective larvae of MTci2, MTci5 or MTci7. Due
to availability of stocks, the infective larvae used to initiate the in-
fections were 1, 4 and 11 months old for MTci7, MTci2 and MTci5,
respectively. All subsequent infections were less than 1 month old
when administered. All larvaewere assessed visually to ensure they
appeared active. Prior to infection all larvae were stored in 100 ml
tapwater in75 cm2 suspension cultureﬂasks (Startsedt Ltd,Germany)
between4and8 °C. At patency, lambswere administeredmonepantel
(Zolvix®, Novartis Animal Heath) at 0.125 mg/kg bodyweight (BW),
1/20th of the manufacturer’s recommended dose rate. The lowest
dose used was selected because previous work had demonstrated
that even a dose of 1.25 mg/kg BW had been effective at removing
>99%of T. circumcinctapopulations (Kaminsky et al., 2009). Eggs from
surviving worms were collected and cultured to generate infective
larvae. Lambswith positive faecal egg counts (FEC) were re-treated
at increasing dose rates of MPTL (e.g. 0.25, 0.5, 0.63, 0.83, 1.25, 1.88
and 2.5mg/kg BW)until egg counts dropped. At this point, the larvae
obtained from the highest dosage were either used to re-infect the
donor that had beenpreviously treated or used to infect a newdonor.
At patency, the process was repeated using increasing dose rates
until a fully resistant isolate, i.e. able to survive a full therapeutic
dose rate (2.5 mg/kg BW), was generated. Further information can
be found in the supplementary material ﬁle attached.
2.3. Monepantel eﬃcacy trial design
The monepantel eﬃcacy trial overall included 10 groups includ-
ing parent (without anthelmintic treatment) and selected (with and
without monepantel administration on day 28, i.e. -CON and -MPTL)
isolates. Five lambs were randomly allocated to each of the 10
groups: MTci2, MTci5, MTci7, MTci7-MPTL, MTci2-11-CON, MTci5-
13-CON, MTci7-12-CON, MTci2-11-MTPL, MTci5-13-MTPL, MTci7-
12-MTPL (Table 1). The group MTci7-MPTL is a treatment validation
group, included for those infected with the parental isolate MTci7,
to conﬁrm that MPTL was effective at removing adult populations
in the original parental isolate. On day 0, Suffolk greyface worm-
free crossbred lambs of 5 to 9 months were challenged per os with
7000 infective larvae from one of the three parental isolates (MTci2,
MTci5 or MTci7) or three monepantel selected isolates (MTci2-11,
MTci5-13 or MTci7-12) according to the constituent of group. Faecal
egg counts were conducted on the lambs prior to the start of the
trial to conﬁrm their worm-free status, and on the day of treat-
ment (day 28) to allow the formation of groups within which all
lambs have similar egg counts. Further FECs were conducted
throughout the trial to assess time to patency and magnitude of egg
output (details in section 2.3.1). On day 28 post-infection, the lambs
were weighed and dosed orally by syringe at themanufacturer’s rec-
ommended dose rate with either Zolvix® (2.5 mg/kg BW; -MPTL)
or left untreated to act as controls (-CON). All anthelmintic
administrations were rounded up to the nearest 0.2ml (dosage range
Table 1
Teladorsagia circumcincta isolate designations pre- (parent) and post-selection for monepantel resistance.
Parental designation Anthelmintic
sensitivity
Designation post
monepantel selection
Designation during
phenotypic characterisation
Original parental characterisation references
BZ LV IV MX
MTci2 S S S S MTci2-11 MTci2-11-CON NA
MTci2-11-MPTL
MTci5 R R R S MTci5-13 MTci5-13-CON (Sargison et al., 2001; Bartley et al., 2005)
MTci5-13-MPTL
MTci7 R R R R MTci7-12 MTci7-12-CON (Sargison et al., 2005; Wilson and Sargison, 2007)
MTci7-12-MPTL
BZ, fenbendazole; LV, levamisole; IV, ivermectin; MX, moxidectin; S, sensitive to anthelmintic class; R, resistant to anthelmintic class; NA, not available.
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2.5–2.7 mg/kg BW). All of the animals were necropsied seven days
post-treatment; themethods used to euthanase the animals, remove
and process their organs for worm burden recovery were as de-
scribed by Patterson et al. (1996). The total worm burdens were
estimated from 2% sub-samples of the abomasal washings and saline
digests. Recovered worms were sexed and staged (MAFF, 1986).
Due to animal, material and time constraints the above trials were
conducted at two separate time points. The controlled eﬃcacy test
(CET) using MTci7 and its selected isolate (MTci7-12) was investi-
gated in one trial whilst MTci2, MTci5, MTci2-11 andMTci5-13 were
investigated in a second trial. All experimental procedures de-
scribed here were approved by the Moredun Research Institute
Experiments and Ethics Committee and were conducted under the
legislation of a UK Home Oﬃce License (reference PPL 60/03899)
in accordance with the Animals (Scientiﬁc Procedures) Act of 1986.
2.3.1. Faecal egg counts
Faecal samples were taken per rectum from each lamb prior to
infection to conﬁrm that theywere negative for nematode eggs: from
day 8 post infection (PI) egg counts, eggs per gram (EPG), were per-
formed three times a week to assess pre-patency of the isolates, on
day 27 PI prior to the anthelmintic treatment (day 28), and then
daily until necropsy seven days later. Faecal egg counts were con-
ducted throughout the trials using a modiﬁcation of a salt ﬂotation
method with a sensitivity of up to one egg per gram (Christie and
Jackson, 1982), allowing the evaluation of the effectiveness of the
anthelmintic on faecal egg count reduction.
2.3.2. Eggs in utero and worm body lengths
Twenty individual adult worms (20 male and 20 female worms
where available) were randomly selected from each lamb within
a group, mounted in a drop of lactophenol (GCC Diagnostics) on a
microscope slide and assessed for fecundity. The numbers of eggs
in utero in female worms were enumerated at magniﬁcation (×40)
on a compound microscope. Images were captured (Nikon D70) of
each individual for length determination; where multiple images
were captured, the images were compiled to form a single com-
posite image using an image editing program (Adobe Photoshop
Elements 4.0). Worm lengths were estimated using image process-
ing software (ImageJ 1.46r).
2.4. Statistical analysis
Themain effects to be investigated were: comparisons between
groups corresponding to the parental isolates (MTci2,MTci5,MTci7),
comparisons between groups corresponding to the parent and se-
lected isolates (versus MTci2-11-CON, MTci5-13-CON, MTci7-12-
CON), and ﬁnally, comparisons between groups corresponding to
the selected isolates without treatment (-CON) andwith treatment
(-MPTL) (versusMTci2-11-MTPL,MTci5-13-MTPL,MTci7-12-MTPL).
2.4.1. Parasite establishment and worm burden
The data on each stage of worm burden (juvenile, male, female
and total) in individual lamb were investigated by ﬁtting a
generalised linear mixed model (GLMM) to the counts using a loga-
rithmic link function and assuming the Poisson distribution.
Estimates of establishment rate (the proportion of juvenile and adult
worms recovered from the initial challenge dose i.e. 7000) and de-
velopment rate (the proportion of adult worms out of total worms
established) were obtained for each group by ﬁtting a GLMMs using
a logit link function and assuming the binomial distribution. All
models included group as a ﬁxed effect, and lamb (the level of each
observation) as a random effect to allow for over-dispersion.
2.4.2. Treatment eﬃcacy
The percentage eﬃcacy of the treatment for each selected isolate
was calculated using the equation: (1-(T/C)) × 100, where C and T
are the arithmetic mean total worm burdens or faecal egg counts
at 35 days PI of the control (-CON) and treated (-MPTL) groups, re-
spectively (Coles et al., 1992). According to Coles et al. (1992),
anthelmintic resistance was deemed to be present when the mean
percentage eﬃcacy at reducing faecal egg output or worm burden
was less than 95%.
2.4.3. Adult worm body length
The data on length of male and female wormswere each analysed
using a linear mixed model (LMM). The model included group as
a ﬁxed effect and lamb as a random effect.
2.4.4. Per capita fecundity
Theworm egg counts in uterowere analysed using a GLMMwith
a logarithmic link function and assuming the Poisson distribution.
The model incorporated the group as a ﬁxed effect and lamb as a
random effect, and worm as a random effect to allow for over-
dispersion. TwoseparateGLMMswere investigated,with andwithout
an offset variable of the logarithm of the female worm length. An
additional GLMMwas also ﬁtted to estimate the effect of logarithm
of the female worm length on the egg counts.
2.4.5. Time to patency
The data on time to patency for each animal were calculated as
the time when the faecal egg count is greater than or equal to 25
eggs per gram. This was analysed using a linear model (LM). The
model included the isolate, combining the two groups for each se-
lected isolate (-CON and -MPTL), as a ﬁxed effect, because days to
patency are before the treatment day (i.e. day 28).
2.4.6. Daily and cumulative faecal egg count
To investigate the effect of group on the faecal egg counts of
lambs, two different approaches were used. First, the logarithm of
faecal egg counts (count+1) data for each lamb on each time point
(day) until day 35 of the experimental period (including both pre
and post-anthelmintic treatment phases) were analysed by an ad-
ditive LMM. The model included group as a ﬁxed effect and separate
smoothing curves for each group to consider the non-linear rela-
tionship of faecal egg count with day. The model incorporated lamb
as a random effect and heterogeneity in variance for each group.
Model selection was based on the Akaike’s information criterion
(AIC). Secondly, to compare the overall faecal egg counts, the cu-
mulative egg count for each lamb during the entire experimental
period was estimated by calculating the area under the curve (AUC)
of EPG using the trapezoid method. A linear model (LM) was ﬁtted
to the square root transformed AUC data for control lambs only, in-
corporating the group as a ﬁxed effect.
2.4.7. General modelling strategy
If all lambs within a group recorded zero values for a response
variable (commonly occurred in the MTci7-MPTL group), there was
no information about lambs within the group; hence the corre-
sponding group was removed before ﬁtting the model to the data.
The overall statistical signiﬁcance of the group (or isolate) was as-
sessed using the F-statistic for the LM, LMM and additive LMM or
chi-square statistic for the GLMM. If the overall test for the group
was statistically signiﬁcant (p < 0.05), a set of biologically interest-
ing contrasts to compare among groups was formulated, and two-
sided probabilities for each contrast were obtained. Finally, these
probabilities were adjusted using a False Discovery Rate (FDR) ap-
proach (Benjamini and Hochberg, 1995) to take into accountmultiple
comparisons of means so that the expected proportion of false posi-
tives among all positives (i.e. rejecting the null hypothesis) was less
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than 5%. The FDR value, denoted in the results here as ‘pf’, there-
fore summarises the strength of evidence for there being a real
difference in a way analogous to a standard p-value. For GLMMs,
and LMs applied to transformed data, estimated means and con-
ﬁdence intervals are back transformed onto the original scale (i.e.
count, proportion, AUC) and tabulated.
All statistical analyses were carried out using R software version
3.1.0 with appropriate R packages (stats, lme4, mgcv, multcomp,
ggplot2) (R Core Team, 2014).
3. Results
3.1. Parasite isolates
Resistance was generated in all three previously susceptible iso-
lates. Parasite survival at a dose rate of 2.5 mg/kg BWwas achieved
after 9, 12 and 13 rounds of selection for MTci5-13, MTci7-12 and
MTci2-11 respectively (see Supplementary material).
3.2. Parasite establishment and worm burden
Group had a statistically signiﬁcant effect on the mean juvenile
(p = 0.004), male (p < 0.001) and total (p = 0.010), and weak evi-
dence for female (p = 0.060) worm burdens in lambs. Table 2 presents
the estimated means and 95% conﬁdence limits of juvenile worms,
males, females and total worm burdens for different isolates. Lambs
from the MTci7 group showed signiﬁcantly lower worm burdens
on average: less males compared with MTci2 (pf = 0.048), MTci5
(pf < 0.001) and MTci7-12-CON (pf = 0.002); less females com-
pared withMTci5 (pf = 0.009) and less total worm burdens compared
with MTci5 (pf = 0.003) and MTci7-12-CON (pf = 0.025).
Group had a statistically signiﬁcant (p = 0.006) effect on themean
parasite establishment rate in lambs (Table 2). Lambs in the MTci7
group showed the lowest mean establishment rate (0.22; 95% CI:
0.12, 0.38) whilst lambs in the MTci2-11-CON group showed the
highest mean establishment rate (0.71; 95% CI: 0.54, 0.84). TheMTci7
group showed a signiﬁcantly lower mean establishment rate com-
pared with MTci5 (pf = 0.003) and MTci7-12-CON (pf = 0.033).
However, no evidence of differences in development rates of worms
among groups was observed (p = 0.101).
3.3. Treatment eﬃcacy
Treatment eﬃcacies based on the percentage reduction in average
estimated total worm burden between treated (-MPTL) and un-
treated (-CON) groups were 48%, 28% and 9% for MTci2-11, MTci7-12
and MTci5-13, respectively (Table 2).
3.4. Adult worm body length
Average body length of adult female worms obtained from each
of the groups measured between 8.6 mm and 9.7 mm in length
(Table 3). Average length of adult male worms ranged between
6.2 mm and 6.9 mm in length. However, there was no evidence that
Table 2
Mean (lower, upper 95% conﬁdence limits) worm burdens of Teladorsagia circumcincta differentiated into male, female, juvenile and expressed as total worm counts as well
as the establishment and development rates of worms estimated from GLMMs. The table also presents the percentage eﬃcacy of anthelmintic treated groups of lambs rel-
ative to untreated control lambs seven days post-treatment. Percentage eﬃcacy is estimated for selected lines only based on the worm burdens of treated lambs (i.e. MTci2-
11-MPTL, MTci5-13-MPTL and MTci7-12-MPTL) relative to untreated control lambs (i.e. MTci2-11-CON, MTci5-13-CON and MTci7-12-CON).
Isolate Worm burden Establishment rate† Development rate$ Percentage
eﬃcacy
Male Female Juvenile Total
MTci2 1275 (862, 1885) 1555 (1026, 2356) 85 (40, 179) 2937 (1990, 4335) 0.45 (0.28, 0.63) 0.97 (0.92, 0.99) NA
MTci5 1783 (1220, 2607) 2562 (1713, 3830) 19 (4, 81) 4395 (2996, 6447) 0.66 (0.48, 0.80) 1.00 (0.96, 1.00) NA
MTci7 560 (361, 868) 948 (612, 1468) 139 (75, 258) 1581 (1051, 2376) 0.22 (0.12, 0.38) 0.92 (0.83, 0.97) NA
MTci2-11-CON 2417 (1666, 3507) 2248 (1499, 3371) 0 4675 (3189, 6854) 0.71 (0.54, 0.84) 1.00 NA
MTci2-11-MPTL 1100 (740, 1635) 1306 (858, 1987) 9 (1, 73) 2444 (1651, 3617) 0.35 (0.21, 0.53) 1.00 (0.90, 1.00) 48
MTci5-13-CON 974 (651, 1459) 1363 (896, 2074) 37 (13, 106) 2409 (1626, 3570) 0.36 (0.21, 0.54) 0.98 (0.92, 1.00) NA
MTci5-13-MPTL 910 (607, 1366) 1232 (807, 1880) 28 (8, 94) 2182 (1470, 3240) 0.32 (0.19, 0.50) 0.99 (0.92, 1.00) 9
MTci7-12-CON 1654 (1129, 2424) 1900 (1262, 2861) 140 (76, 260) 3699 (2515, 5440) 0.57 (0.39, 0.74) 0.96 (0.91, 0.98) NA
MTci7-12-MPTL 1168 (785, 1737) 1467 (965, 2229) 56 (23, 136) 2654 (1792, 3929) 0.44 (0.28, 0.63) 0.98 (0.93, 1.00) 28
† The establishment rate is deﬁned as the proportion of juvenile and adult worms out of total infected worms (i.e. 7000).
$ The development rate is deﬁned as the proportion of adult worms out of total worms established.
NA, Not applicable since the percentage eﬃcacy is estimated for the selected lines only.
Table 3
Summary of life history traits of Teladorsagia circumcincta isolates before and after selection for monepantel resistance. Values are means (lower, upper 95% conﬁdence
limits) estimated from GLMMs, LMMs and LMs.
Isolate Adult worm length (mm) Eggs in utero Eggs in utero per mm
body length
Time to patency†
(days PI)
Total cumulative faecal
egg count$
Female Male
MTci2 8.9 (8.3, 9.5) 6.5 (6.1, 6.9) 21 (16, 28) 2.4 (1.9, 3.1) 19 (16, 22) 2826 (1037, 5495)
MTci5 9.5 (8.9, 10.2) 6.7 (6.3, 7.2) 28 (21, 37) 3.0 (2.3, 3.8) 18 (15, 22) 6898 (3855, 10820)
MTci7 8.6 (7.9, 9.2) 6.2 (5.8, 6.6) 19 (14, 25) 2.2 (1.7, 2.9) 20 (18, 22) 1546 (337, 3635)
MTci2-11-CON 9.7 (9.1, 10.3) 6.7 (6.3, 7.1) 25 (19, 33) 2.6 (2.1, 3.3) 16 (14, 18) 8067 (4741, 12273)
MTci2-11-MPTL 9.6 (8.9, 10.2) 6.9 (6.5, 7.2) 13 (10, 17) 1.4 (1.1, 1.8) NA NA
MTci5-13-CON 9.0 (8.4, 9.7) 6.7 (6.3, 7.1) 18 (13, 24) 2.0 (1.6, 2.6) 19 (17, 21) 2949 (1111, 5665)
MTci5-13-MPTL 9.0 (8.4, 9.6) 6.4 (6.1, 6.8) 23 (18, 31) 2.6 (2.0, 3.3) NA NA
MTci7-12-CON 9.7 (9, 10.3) 6.8 (6.4, 7.2) 28 (21, 37) 2.9 (2.3, 3.7) 15 (13, 18) 10215 (6417, 14893)
MTci7-12-MPTL 9.4 (8.7, 10.0) 6.7 (6.2, 7.1) 30 (23, 40) 3.3 (2.5, 4.2) NA NA
† Time to patency was calculated as faecal egg count >25 eggs per gram; data for selected lines combined, therefore no data quoted for monepantel (MPTL) treated groups
(marked as NA, not applicable).
$ Estimated total faecal egg counts over the course of the trial; the outcomes for selected lines of monepantel (MPTL) treated groups were not estimated (marked as NA,
not applicable).
PI, post infection.
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average worm body length differed between the groups (p = 0.242
and 0.193 for male and female, respectively).
3.5. Per capita fecundity
Average number of eggs in utero (EIU) for each of the groups
ranged between 13 and 30 (Table 3). The female worm length had
a statistically signiﬁcant effect (p < 0.001) on mean EIU, and each
mm increase in the female worm length resulted in a 30% in-
crease of mean EIU. Group also had a statistically signiﬁcant
(p = 0.005) effect on the mean EIU. Results suggested that the mean
EIU did not differ signiﬁcantly (pf > 0.310) among the parental iso-
lates, but the group MTci2-11-CON had signiﬁcantly (pf = 0.010)
higher mean EIU (25, 95% conﬁdence limits: 19, 33) than the MTci2-
11-MPTL (13, 95% conﬁdence limits: 10, 17). Results were similar
when the estimates of EIU for different groups were adjusted for
the female worm length.
3.6. Time to patency
The time to patency, for this study, is deﬁned as the time when
a lamb produced a faecal egg count ≥ 25 eggs per gram. The esti-
mated mean time to patency (lower, upper 95% conﬁdence limits)
were 19 (16, 22), 18 (15, 22) and 20 (18, 22) days post-infection
for the parental isolates MTci2, MTci5 and MTci7, respectively; and
16 (14, 18), 19 (17, 21) and 15 (13, 18) days for the MPTL selected
isolates MTci2-11, MTci5-13 and MTci7-12, respectively (Table 3).
The effect of group on the mean time to patency showed a weak
evidence (p = 0.052). The mean time to patency among the paren-
tal isolates and among the selected isolates were not statistically
signiﬁcant (pf > 0.925). Although the mean time to patency short-
ened for two of the three selected isolates following selection, only
MTci7-12 had signiﬁcant (pf = 0.048) shortening compared with its
parental isolates MTci7.
3.7. Daily faecal egg count
Figure 1 presents the observed FEC data as well as the mean FECs
and corresponding 95% conﬁdence limits for each of the groups over
the time course of the study. The interaction effect of group and
smooth term for day was statistically signiﬁcant (p < 0.001). Lambs
of all groups started excreting eggs between days 14 and17 PI, and
showed an increasing trend until the anthelmintic treatment on day
28 PI (Figure 1). Estimatedmean faecal egg counts (95% lower, upper
conﬁdence limits) at day 28 PI for different isolates of parent and
selected control lambs were: MTci2 (125; 95% conﬁdence limits 57,
273); MTci2-11-CON (317; 136, 738); MTci5 (294; 142, 606); MTci5-
13-CON (94; 42, 208); MTci7 (69; 31, 149) and MTci7-12-CON (499;
Fig. 1. The mean (line) faecal eggs counts (egg per gram, EPG) of lambs infected with either parental (MTci2, MTci5, MTci7) or monepantel selected (MTci2-11, MTci5-13,
MTci7-12) isolates over the course of the study and corresponding 95% conﬁdence limits (shaded region) estimated from the linear mixed model (LMM). Observed indi-
vidual faecal egg counts are shown as closed circles. Groups in each panel represent parent isolates and selected isolates with (-MPTL) or without (-CON) monepantel treatment
(on day 28 post-infection) i.e. MTci2, MTci5, MTci7, MTci7-MPTL, MTci2-11-CON, MTci2-11-MTPL, MTci5-13-CON, MTci5-13- MTPL, MTci7-12-CON, MTci7-12-MTPL.
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217, 1146) EPG. The mean egg count in the parental isolate MTci5
was higher than the parental isolate MTci7 on day 28 post infec-
tion, but the strength of evidence was weak (pf = 0.057). At the same
time point, the mean egg count in the selected isolate MTci7-12-
CON was signiﬁcantly (pf = 0.006) higher compared with its
corresponding parental isolate MTci7.
At post mortem examination (day 35 PI), the anthelmintic treat-
ment eﬃcacy based on the percentage reduction in FEC of treated
versus untreated animals were 86%, 11% and 1% for MTci2-11, MTci7-
12 and MTci5-13, respectively.
3.8. Cumulative faecal egg count
Figure 1 shows scatter plots of individual animals of each of the
groups over the time course of the study. Table 3 presents the es-
timated mean cumulative faecal egg count for isolates of control
parent and selected lambs and corresponding 95% lower and upper
conﬁdence limits for the different groups. Group had a statistical-
ly signiﬁcant (p = 0.002) effect on the mean cumulative faecal egg
counts in lambs. Among the parental isolates, the MTci7 had the
lowest (1546; 95% CI: 337, 3635) and MTci5 had the highest (6898;
95% CI: 3855, 10820) estimated mean cumulative faecal egg counts,
and these two parental isolates were signiﬁcantly different
(pf = 0.040). Among the selected isolates, MTci5-13-CON had the
lowest estimate (2949; 95% CI: 1111, 5665) and MTci7-12-CON had
the highest estimate (10215; 95% CI: 6417, 14893) of cumulative
faecal egg counts. The mean cumulative egg count in the selected
isolate MTci7-12-CON was signiﬁcantly higher compared with the
parental isolate MTci7 (pf = 0.002). Interestingly, MTci5-13-CON
showed lower mean cumulative egg counts compared with its pa-
rental isolate (MTci5), although the difference was not statistically
signiﬁcant (pf = 0.278).
4. Discussion
Selection for monepantel resistance was “successful” in three dis-
crete T. circumcincta isolates with different phenotypic sensitivities
to “traditional” broad-spectrum anthelmintics. Selection was
achieved after 9, 12 and 13 rounds of selection for MTci5-13, MTci7-
12 and MTci2-11 respectively.
All selected parasite isolates were conﬁrmed as MPTL resis-
tant; the estimated resistance status of the selected isolates was
conﬁrmed with 48%, 28% and 9% reductions in worm burden at
7-days post Zolvix® administration for MTci2-11-MPTL, MTci5-13-
MPTL and MTci7-12-MPTL, respectively, compared with untreated
controls.
A selection process of administering increasing sub-therapeutic
dosages to phenotyically characterised parental isolates was chosen
for this work because it allowed the generation of a resistant pop-
ulation arising from a common ancestry which would allow future
genotypic assessments. This process has been successfully used
earlier to generate material to examine a number of candidate genes
associated with benzimidazole (Beech et al., 1994; Lubega et al.,
1994) and macrocyclic lactone (Blackhall et al., 1998a, 1998b, 2003;
Paiement et al., 1999) resistance as well as to investigate non-
speciﬁc mechanism of resistance (Molento and Prichard, 2001). Very
little work has been conducted on T. circumcincta, but previous
reports of artiﬁcial selection for anthelmintic resistance appear to
be longer in this species than in other species. Workers using similar
procedures to select BZ (Kates et al., 1973; Colglazier et al., 1974b)
or ML (Egerton et al., 1988; Echevarria et al., 1993a; Rohrer et al.,
1994; Ranjan et al., 2002; Coles et al., 2005) resistance in Haemon-
chus contortus generated it within 3 to 22 generations. Giordano et al.
(1988) reported that selection pressures applied to a mixed pop-
ulation of nematode species selected for ivermectin resistancewithin
four generations in Trichostrongylus colubriformiswhilst T. circumcincta
and H. contortus remained sensitive to the treatment in that time
period. In T. circumcincta, morantel, levamisole and thiabendazole
resistance was selected after around three years of selection pres-
sure (no actual generations times stated; Le Jambre et al., 1977).
Potential reasons for these inter- and intra-species differences may
reﬂect the isolates’ previous exposure to compounds of interest
(Kates et al., 1973), inherent sensitivities to the compounds, e.g.,
dose limiting species (Thomas and Reid, 1980; Armour et al., 1982);
initial frequency of “potential” gene(s) for resistance within the pop-
ulation; dominance/recessive nature of inheritance; whether
resistance is monogenic or polygenic or the impact of non-speciﬁc
mechanisms of resistance on the ability of an isolate to survive the
effects of an anthelmintic. The complexity of the situation means
that changes in the phenotypes and genotypes of nematode popu-
lations as a result of anthelmintic usage is unlikely to be the same
across the board.
The length of time to generate resistance is diﬃcult to accu-
rately calculate within this type of selection process, although a
conservative estimate would suggest that resistance was selected
within 9–13 generations, albeit the genes for resistance may have
been selected sooner. In the ﬁeld the ﬁrst reported cases of MPTL
resistance occurred two years after the launch of the Zolvix® in New
Zealand, where treatment failure against T. circumcincta and
T. colubriformis occurred after intense (17 separate occasions) dosing
strategies (Leathwick et al., 2013; Scott et al., 2013).
Although the intensity of the selection process is signiﬁcantly
more rapid than that seen in the ﬁeld, it is conceivable that re-
infection of hosts predominantly with the progeny of worms that
have survived anthelmintic treatment could occur. An examplewould
be when the number of infective larvae in refugia, i.e. the parasite
population that is unexposed to anthelmintic treatment that is avail-
able to be ingested by a host, is extremely low. This phenomenon
has been shown to rapidly select for anthelmintic resistance in the
ﬁeld. Benzimidazole (Papadopoulos et al., 2001) and IVM (Besier
and Love, 2003; Suter et al., 2004) resistance is believed to have been
selected when animals were treated around dry season and sub-
sequentlymoved to “safe/clean” pasture (Cawthorne andWhitehead,
1983; Martin et al., 1985). Rapid selection occurs because, even with
only a small number of survivors, they form the only individuals
available for re-infection of stock.
Because health programmes alter nematodemortality, they force
the parasites to evolve or face extinction. One way that organisms
do this is through changing their strategies/life history traits (Paterson
and Barber, 2007; Lynch et al., 2008). In addition to differences in
the time scale of the selection for resistance, it would be expected
that phenotypes such as life history traits would be different within
different isolates/populations and species. Differences in life history
traits have been observed both following artiﬁcial and ﬁeld selec-
tion of resistance to a number of different anthelmintic drug classes
(Kelly et al., 1978; Hall et al., 1981; Echevarria et al., 1993a; Elard
et al., 1998; Skorping and Read, 1998; Leignel and Cabaret, 2001;
Sutherland et al., 2002). Historically, it has been stated that inter-
ventions such as vaccination or chemotherapy, which potentially
impact on the survival of the organism, would result in smaller, faster
developing, less fecund worms (Medley, 1994; Poulin and Morand,
1997; Lynch et al., 2008). In situations where chances of survival
are perceived to be high, the slower growing, larger andmore fecund
individuals would proliferate (Lynch et al., 2008) even though larger
size has been correlated with increased pathogenicity (Stear et al.,
1999). It is believed that the environmental conditions, be that within
or out with the host, under which a parasite develops can inﬂu-
ence the phenotype of that organism. Changes in growth, fecundity
or mortality, for example, can traditionally occur in two ways; phe-
notypic plasticity whereby an organism produces a number of
progeny of different phenotypes under different conditions, or ge-
notypic adaptation where there is a shift in genotype frequency to
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one that is better suited to new conditions (Stearns, 1992). Pheno-
typic plasticity was believed to be the reserve of prokaryotic
organisms such as bacteria, but work on trematodes has shown that
even within parasite populations there is the capacity to acceler-
ate development and reach precocious maturity sooner if conditions
require (Poulin, 2003).
Assessment of the life history traits of the MPTL selected iso-
lates showed that in one of the cases (MTci7-12) statistically
signiﬁcant differences were observed in a number of the pheno-
typic traits assessed in relationship to survivability and propagation
i.e. establishment rate, time to patency, per capita fecundity and
overall egg output. Establishment has been suggested as the most
important of the life history traits and also the one most diﬃcult
to compare experimentally (Chehresa, 1996). The ﬁndings from this
current study suggested that the selected isolates had higher es-
tablishment rates comparedwith their derivatives with the exception
MTci5-13. The ﬁndings are in general agreement with previous ones
which showed that the establishment of resistant isolates were the
same or higher than unselected isolates in resistantH. contortus (Kelly
et al., 1978; Hall et al., 1981; Echevarria et al., 1993a) and
T. circumcincta (Hall et al., 1981; Elard et al., 1998).
Overall net cumulative egg production and per capita fecundi-
ty increased in magnitude for MTci2-11 and MTci7-12 whilst a
reduction was observed with MTci5-13 compared with correspond-
ing parental isolates, although the increasewas statistically signiﬁcant
only for the cumulative egg production in the MTci7-12 isolate.
Taking into account the greater female burdens carried by these in-
dividual hosts, cumulative egg outputs were 3 to 7 times greater
than the parental isolates. Previous studies reported similar ﬁnd-
ings in populations selected for IVM resistance (Kelly et al., 1978;
Sutherland et al., 2002) whilst others found only transient in-
creases in egg excretion (Maingi et al., 1990). As previously observed,
the increase in egg numbers in utero was related to increase in the
worm body length (Skorping and Read, 1998; Leignel and Cabaret,
2001). In the current study, one mm increase in female body length
resulted in 30% increase in eggs in utero.
In the early stages of resistance, particularly with the ML’s, sup-
pression in the generation and/or oviposition of eggs in adult female
worms that survive treatment has been observed (McKellar et al.,
1988; Sargison et al., 2005; Bartley et al., 2012). The impact is be-
lieved to be due to temporary paralysing effects of the anthelmintics
on uterinemusculature (Scott et al., 1991;McKenna, 1997). The result
is the suppression in egg output in surviving worms whilst the drug
is at a particular level which resumes when the drug concentra-
tion falls. McKellar et al. (1988) also suggested that dosing events
may damage the worms so that although they survive, they will not
contribute greatly to future populations. Analysis of historical faecal
egg count data in conjunction with data from passage donors would
suggest that the long term survivability of the selected isolates is
no shorter than their parental counterparts, i.e. patency in donor
animals used for propagation of isolates is similar irrespective of
resistance status.
Although the work highlighted here would suggest that changes
in life history traits may occur in response to anthelmintic selec-
tion, it must also be acknowledged that other factors may play roles.
Phenotypic changes between the parental and/or selected isolates
could (a) have occurred due to chance linkage events (Gilleard, 2006;
Gilleard and Beech, 2007), with the life history trait being passed
down to the progeny through the selection process, (b) be con-
founded by trial to trial effects and/or (c) through the passaging/
culturing of the isolates for generations through lambs under
laboratory conditions.
In conclusion, the study has established that MPTL resistance can
be artiﬁcially selected in T. circumcincta in as short a time frame as
nine generations. Selection for resistance impacted on the life history
traits of the isolates, but the ﬁndings re-iterate the points stated
earlier that it is diﬃcult to predict what may occur to a parasite pop-
ulation following anthelmintic treatment.
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